Picture Berlin Partner Top News Captain T Cell Therapies 650x100px

News > All

Total search results: 3657 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 6 7 8 ... 35 36 37  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Medigene AG. (5/3/23). "Press Release: Medigene AG Reports Financial Results and Business Update for Q1 2023". Martinsried. 2023-05-03
MicrofluidX Ltd.. (5/2/23). "Press Release: MicrofluidX and Immatics Working Together on Automated End-to-End Bioprocessing for TCR-T Therapies". Stevenage & Houston, TX. 2023-05-02
LifeArc. (5/2/23). "Press Release: Dr Jason Slingsby Joins LifeArc as Chief Business Officer". 2023-05-02
Bionter AG. (5/2/23). "Press Release: Ten23 Health, a Swiss-based CDMO and Bionter, a Premium Supplier of Analytical Ttesting Technology, Announced Today Their Collaboration to Advance Innovative Testing Methods of Particulate Matter". Basel. 2023-05-02
Medigene AG. (5/2/23). "Press Release: Medigene Acquires Worldwide, Exclusive License of CD40L-CD28 Costimulatory Switch Receptor". Planegg. 2023-05-02
Immatics N.V.. (5/2/23). "Press Release: Immatics Reports Interim Clinical Data from Ongoing Phase 1b Cohort A Monotherapy with ACTengine IMA203 TCR-T Targeting PRAME". Houston, TX & Tübingen. 2023-05-02
Anavo Therapeutics B.V.. (5/2/23). "Press Release: Anavo Therapeutics Extends Seed Round to EUR 28 Million to Advance Pipeline of Novel Phosphatase Modulators Toward the Clinic". Leiden & Heidelberg. 2023-05-02
Memo Therapeutics AG. (5/2/23). "Press Release: Memo Therapeutics AG Receives FDA Fast Track Designation for AntiBKV as Treatment of BKV Infection in Renal Transplant Patients". Schlieren. 2023-05-02
Immatics N.V.. (5/1/23). "Press Release: Immatics Announces First Bristol Myers Squibb Opt-in of TCR-T Candidate from Ongoing Multi-target Strategic Collaboration". Tübingen & Houston, TX. 2023-05-01
Seres Therapeutics, Inc.. (4/26/23). "Press Release: Seres Therapeutics and Nestlé Health Science Announce FDA Approval of Vowst (fecal microbiota spores, live-brpk) for Prevention of Recurrence of C. difficile Infection in Adults Following Antibacterial 2023-04-26
va-Q-tec AG. (4/26/23). "Press Release: Sartorius and va-Q-tec Announce a Long-term Partnership for the Joint Development of Innovative Transport Systems for the Biopharmaceutical Industry". Würzburg & Göttingen. 2023-04-26
ImmunOs Therapeutics AG. (4/25/23). "Press Release: ImmunOs Therapeutics Appoints Michael A. Curran, PhD, as Chairman of its Scientific Advisory Board". Schlieren & Gaithersburg, MD. 2023-04-25
Boehringer Ingelheim. (4/24/23). "Press Release: Boehringer Ingelheim Inaugurates Largest European Development Centre for Biotechnology". Ingelheim. 2023-04-24
3B Pharmaceuticals GmbH. (4/24/23). "Press Release: 3B Pharmaceuticals Enters into a Global Exclusive Licensing Agreement for its FAP-Targeting Peptide Technology". Berlin. 2023-04-24
Biotalys N.V.. (4/24/23). "Press Release: Syngenta and Biotalys Enter into Strategic Partnership in Biologicals Innovation to Advance Solutions for Sustainable Agriculture". Basel & Ghent. 2023-04-24
Tubulis GmbH. (4/20/23). "Press Release: Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients". Munich. 2023-04-20
Lifespin GmbH. (4/20/23). "Press Release: Lifespin Announces Inaugural Membership in the Industrial Participant Program of the Wyss Diagnostics Accelerator at Harvard University". Regensburg & Boston, MA. 2023-04-20
Forbion Capital Partners. (4/19/23). "Press Release: Forbion Raises €1.35 Billion across Two Funds". Espoo. 2023-04-19
EniferBio Ltd.. (4/19/23). "Press Release: EniferBio raises €11M to Make Planet-friendly Fungal Protein from the By-products of food and agricultural processes". Espoo. 2023-04-19
Gilde Healthcare Partners. (4/19/23). "Press Release: Gilde Healthcare Raises €600 Million to Invest in Healthcare innovation". Utrecht. 2023-04-19
VectivBio Holding AG. (4/19/23). "Press Release: VectivBio Reports Full Year 2022 Financial Results and Provides Business Update". Basel. 2023-04-19
InflaRx N.V.. (4/18/23). "Press Release: InflaRx Announces Closing of the Full Exercise of Greenshoe Option Increasing the Proceeds of the Recently Announced Public Offering of Ordinary Shares to US$46 million". Jena. 2023-04-18
Zetta Genomics Ltd.. (4/18/23). "Press Release: Zetta Genomics Secures £1.9 Million in Second Round Seed Funding to Configure for Scale, Delivery and Innovation". 2023-04-18
Ariceum Therapeutics GmbH. (4/18/23). "Press Release: Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline". Berlin. 2023-04-18
Lunaphore Technologies S.A.. (4/17/23). "Press Release: Bio-Techne and Lunaphore Establish Strategic Partnership to Develop the First Fully Automated Same-slide Spatial Multiomics Solution". Minneapolis, MN & Lausanne. 2023-04-17
Pieris Pharmaceuticals, Inc.. (4/17/23). "Press Release: Pieris Pharmaceuticals Announces Presentation of Positive Clinical Data for Cinrebafusp Alpa (PRS-343) At 2023 AACR Annual Meeting". Boston, MA. 2023-04-17
Complement Therapeutics GmbH. (4/17/23). "Press Release: Complement Therapeutics Secures €72 Million in Series A Financing to Advance Novel Therapies Targeting Complement-Mediated Diseases". Munich. 2023-04-17
ITM Isotope Technologies Munich SE. (4/17/23). "Press Release: ITM Appoints Roger Estafanos as U.S. General Manager and Expands Presence with Opening of U.S. Headquarters in Princeton, New Jersey". Garching & Princeton, NJ. 2023-04-17
Ginkgo Bioworks Inc.. (4/17/23). "Press Release: Ginkgo Bioworks and Syngenta Seeds Announce Collaboration to Develop New Traits for the Next Generation of Seed Technology". Boston, MA. 2023-04-17
InflaRx N.V.. (4/14/23). "Press Release: InflaRx Announces Closing of $40 Million Public Offering of Ordinary Shares". Jena. 2023-04-14
CellPhenomics GmbH. (4/14/23). "Press Release: CELLphenomics’ and Kyan Therapeutics Combined Platforms Provide Best-in-Class Solutions to Support the Biopharma Industry". Berlin & Singapore. 2023-04-14
Alentis Therapeutics AG. (4/13/23). "Press Release: Alentis Therapeutics Closes $105 Million Series C Funding to Advance Transformational Medicines for Claudin-1". Basel. 2023-04-13
CRISPR Therapeutics AG. (4/13/23). "Press Release: CRISPR Therapeutics to Participate in Needham’s 22nd Annual Healthcare Conference". Zug & Cambridge, MA. 2023-04-13
EXTEND Technology Transfer Hub. (4/12/23). "Press Release: EXTEND Approve Investmnet on Two Projects from San Raffaele Hospital to Tackle Devastating Rare Diseases". Rome. 2023-04-12
InflaRx N.V.. (4/11/23). "Press Release: InflaRx Announces Pricing of $40 Million Public Offering of Ordinary Shares". Jena. 2023-04-11
InflaRx N.V.. (4/11/23). "Press Release: InflaRx Announces Public Offering of Ordinary Shares". Jena. 2023-04-11
Proxygen GmbH. (4/5/23). "Press Release: Proxygen Announces Collaboration and License Agreement with MSD". Vienna. 2023-04-05
Syncona Ltd.. (4/5/23). "Press Release: Syncona Appoints Roel Bulthuis as Managing Partner". 2023-04-05
Biocartis Group N.V.. (4/4/23). "Press Release: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla Platform". Mechelen. 2023-04-04
Eckert & Ziegler AG. (4/4/23). "Press Release: Eckert & Ziegler to Supply Point Biopharma with Actinium-225". Berlin & Indianapolis, IN. 2023-04-04
Crown Bioscience, Inc.. (4/4/23). "Press Release: Crown Bioscience Announces Transaction Closing of Indivumed’s Service Business and Supporting Biobank". San Diego, CA. 2023-04-04
Quantro Therapeutics GmbH. (4/4/23). "Press Release: Quantro Therapeutics Appoints Industry Expert Dr. Michael Bauer as Chief Executive Officer". Vienna. 2023-04-04
InflaRx N.V.. (4/4/23). "Press Release: InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients". Jena. 2023-04-04
AMSilk GmbH. (4/4/23). "Press Release: AMSilk Announces Extension of Series C Financing to EUR 54M". Munich. 2023-04-04
AiCuris Anti-infective Cures AG. (4/4/23). "Press Release: AiCuris AG Announces Appointment of Larry Edwards as Chief Executive Officer and Formation of U.S. Subsidiary". Cambridge. 2023-04-04
CRISPR Therapeutics AG. (4/3/23). "Press Release: CRISPR Therapeutics and Vertex Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for Exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalas 2023-04-03
PolyPeptide Group AG. (4/3/23). "Press Release: PolyPeptide Appoints Juan-José Gonzalez as CEO and Announces Change of CFO". Baar. 2023-04-03
Sartorius. (3/31/23). "Press Release: Sartorius to Acquire Polyplus. France-based Polyplus Is a Provider of Innovative Upstream Technologies for Cell and Gene Therapies". Göttingen. 2023-03-31
InSphero AG. (3/31/23). "Press Release: InSphero Accelerates Launch of Cryopreserved 3D Microtissue Platform with New Investment Round Led by Zeiss Ventures". Zürich. 2023-03-31
Nagi Bioscience S.A.. (3/29/23). "Press Release: Nagi Bioscience Launches SydLab One". Lausanne. 2023-03-29
CRISPR Therapeutics AG. (3/29/23). "Press Release: CRISPR Therapeutics Announces Departure of Board Member". Zug & Boston, MA. 2023-03-29
InfanDx AG. (3/28/23). "Press Release: InfanDx AG Revises Strategy and Broadens Diagnostics Pipeline for Child Health". Cologne, Berlin & Boston, MA. 2023-03-28
Thermosome GmbH. (3/28/23). "Press Release: Thermosome Receives Regulatory Approval for First-In-Human Trial with its Lead Program THE001". Munich. 2023-03-28
Bicycle Therapeutics plc. (3/28/23). "Press Release: Bicycle Therapeutics Announces a Strategic Collaboration with Novartis to Discover, Develop and Commercialize Bicycle® Radio-Conjugates". Cambridge & Boston, MA. 2023-03-28
Deepc GmbH. (3/28/23). "Press Release: Digital Medicine Pioneer, Deepc, Announces €12 Million Series A Round Led by Sofinnova Partners". 2023-03-28
Secarna Pharmaceuticals GmbH & Co. KG. (3/27/23). "Press Release: Secarna Pharmaceuticals and SciNeuro Pharmaceuticals Enter into Research and Option Agreement in the Field of CNS Diseases". Martinsried. 2023-03-27
CRISPR Therapeutics AG. (3/27/23). "Press Release: CRISPR Therapeutics and Vertex Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes". Boston, MA & Zug. 2023-03-27
Collaborative Drug Discovery, Inc.. (2/23/23). "Press Release: German Drug Development Company Prosion Therapeutics Selects CDD Vault to Host Its R&D Data". Cologne & San Francisco, CA. 2023-03-23
Mbiomics GmbH. (3/23/23). "Press Release: Microbiome Therapeutics Biotech Mbiomics Raises EUR 13 Million in First Closing of Series A Round". Munich. 2023-03-23
Lunaphore Technologies S.A.. (3/23/23). "Press Release: Lunaphore Raises CHF40M in the First Close of Series D Funding Led by EGS Beteiligungen AG". Lausanne. 2023-03-23
Roche. (3/22/23). "Press Release: Roche Announces Collaboration with Lilly to Enhance Early Diagnosis of Alzheimer's Disease". Basel. 2023-03-22
Berkeley Lights, Inc.. (3/21/23). "Press Release: Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company". Emeryville, CA. 2023-03-21
BioNTech AG. (3/20/23). "Press Release: BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications". Mainz & Rockville, MD. 2023-03-20
Scailyte AG. (3/16/23). "Press Release: Scailyte Announces Collaboration with Turnstone Biologics". Basel. 2023-03-16
High-Tech Gründerfonds Management GmbH. (3/16/23). "Press Release: Successful Exit for HTGF. Miltenyi Biotec Acquires Biosensor Company Lino Biotech". Zurich. 2023-03-16
Seamless Therapeutics GmbH. (3/16/23). "Press Release: Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases". Dresden. 2023-03-16
Mediar Therapeutics Inc.. (3/15/23). "Press Release: Mediar Therapeutics Announces $105 Million Financing to Advance Portfolio of First-in-Class Fibrosis Therapies". Cambridge, MA. 2023-03-15
Proxygen GmbH. (3/15/23). "Press Release: Proxygen Announces Formation of Board of Directors". Vienna. 2023-03-15
Lino Biotech AG. (3/15/23). "Press Release: Miltenyi Biotec Acquires Biosensor Company Lino Biotech". Zürich. 2023-03-15
BioNTech AG. (3/14/23). "Press Release: Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years". New York & Mainz. 2023-03-14
Bayer AG. (3/14/23). "Press Release: BlueRock Therapeutics to Incorporate Wearable and Invisible Contactless Digital Health Technologies from Rune Labs and Emerald Innovations in Parkinson’s Disease Clinical Trial". Cambridge. 2023-03-14
MorphoSys AG. (3/14/23). "Press Release: Lucinda Crabtree to Join MorphoSys as Chief Financial Officer". Planegg. 2023-03-14
Bayer AG. (3/14/23). "Press Release: Bayer Collaborates with Microsoft to Unveil New Cloud-based Enterprise Solutions, advancing innovation and transparency in the agri-food industry". San Francisco, CA. 2023-03-14
CRISPR Therapeutics AG. (3/13/23). "Press Release: CRISPR Therapeutics Announces Transition of Chief Financial Officer". Zug & Boston, MA. 2023-03-13
BioNTech AG. (3/13/23). "Press Release: Update on First BioNTainer for African-based mRNA Manufacturing Facility". Mainz & Kigali. 2023-03-13
InSphero AG. (3/13/23). "Press Release: Vrije Universiteit Brussel (VUB) and InSphero Partner to Advance Drug Discovery for Non-Alcoholic Steatohepatitis". Schlieren. 2023-03-13
VectivBio Holding AG. (3/13/23). "Press Release: VectivBio and Asahi Kasei Pharma Announce the Start of a Phase 1 Study of Apraglutide in Japan". Basel. 2023-03-13
Bayer AG. (3/9/23). "Press Release: AskBio Announces Gustavo Pesquin as New CEO". Research Triangle Park, NC. 2023-03-09
Iktos SAS. (3/9/23). "Press Release: Iktos Raises € 15.5m Series A Round to Expand Its Artificial Intelligence-based Drug Discovery Technologies and Solutions". Paris & Lausanne. 2023-03-09
Cellbox Solutions GmbH. (3/7/23). "Press Release: Cellbox Solutions Raises EUR 6.5 Million in Series A1 Financing Round". Norderstedt. 2023-03-07
Exscientia plc. (3/7/23). "Press Release: Exscientia Announces Collaboration with Charité to Advance Development of Precision Medicine Platform". Oxford & Berlin. 2023-03-07
Noema Pharma AG. (3/7/23). "Press Release: Noema Pharma Raises CHF 103 million (USD 112 million) in Series B Financing Round Led by Forbion and Jeito Capital". Basel. 2023-03-07
Eppendorf SE. (3/6/23). "Press Release: Eppendorf Divests Micro Manipulation Product Portfolio". Hamburg. 2023-03-06
Oculis Holding AG. (3/3/23). "Press Release: Oculis Announces US Public Listing on NASDAQ". Lausanne & Zug. 2023-03-03
MorphoSys AG. (3/2/23). "Press Release: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs". Planegg. 2023-03-02
SHS Gesellschaft für Beteiligungsmanagement mbH. (3/2/23). "Press Release: More Patient Safety with Simulators for Cardiologists – SHS Invests 10 Million Euro in Swiss Simulands AG". Tübingen. 2023-03-02
BioNTech AG. (3/1/23). "Press Release: BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel". Jerusalem. 2023-03-01
High-Tech Gründerfonds Management GmbH. (2/28/23). "Press Release: Almost 500 Million for Investments in Start-ups. Final Closing Exceeds Expectations for HTGF". Bonn. 2023-02-28
Bico Group AB. (2/27/23). "Press Release: Bico Introduces New Life Sciences Manufacturing Platform Integrating ABB Robotics Technology". 2023-02-27
CRISPR Therapeutics AG. (2/27/23). "Press Release: CRISPR Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference". Zug & Boston, MA. 2023-02-27
VisionHealth GmbH. (2/27/23). "Press Release: VisionHealth Raises 3 Million Euro to Finance Extended COPD and Asthma Study for Market Preparation of Kata, an Innovative Digital Therapeutic for Improved Inhalation". Munich. 2023-02-27
ObsEva S.A.. (2/24/23). "Press Release: ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland". Geneva. 2023-02-24
CrystalsFirst GmbH. (2/23/23). "Press Release: CrystalsFirst Establishes Partnership with Akttyva Therapeutics to Support AI-powered Drug Discovery Programs". Hamburg. 2023-02-23
High-Tech Gründerfonds Management GmbH. (2/22/23). "Press Release: MedTech Startup HBOX Therapies Receives €2.3m in Seed Funding for Protective Lung Support". Aachen. 2023-02-22
Paleo B.V.. (2/22/23). "Press Release: Paleo Raises €12M to Bring the Real Taste of Meat to Plant-based Foods". Brussels. 2023-02-22
Resalis Therapeutics S.r.l.. (2/22/23). "Press Release: Resalis Therapeutics Raises €10 Million Series A to Complete First Clinical Trial for RES-010 in Obesity". Torino. 2023-02-22
Resalis Therapeutics S.r.l.. (2/22/23). "Press Release: Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases". Torino. 2023-02-22
Endress+Hauser AG. (2/21/23). "Press Release: Endress+Hauser Initiates Generational Change. Dr Klaus Endress to Leave the Supervisory Board by the End of the Year; Matthias Altendorf Named as Successor; Dr Peter Selders Will Become CEO". 2023-02-21
CRISPR Therapeutics AG. (2/21/23). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results". Zug & Boston, MA. 2023-02-21
Friedrich-Alexander-Universität Erlangen-Nürnberg. (2/20/23). "Press Release: Testing Their Strength –CAR T-cells Combat Muscle Inflammation. Universitätsklinikum Erlangen the First in the World to Use a Pioneering New Method to Successfully Treat a Pati 2023-02-20
next pagenext page 1 2 3 ... 6 7 8 ... 35 36 37  next pagenext page


Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture EBD Group World of Partnering Opportunities 650x300px

» top